Procyon Corporation

PINK:PCYN USA Drug Manufacturers - Specialty & Generic
Market Cap
$1.47 Million
Market Cap Rank
#36614 Global
#11912 in USA
Share Price
$0.18
Change (1 day)
+0.00%
52-Week Range
$0.18 - $0.18
All Time High
$0.95
About

Procyon Corporation, together with its subsidiaries, manufactures and markets wound and skin care products primarily in the United States. It provides AMERIGEL, an advanced skin and wound care products, including hydrogel wound dressing, post op surgical kits, saline wound washes, and care and barrier lotions; HELIX3 Bioactive Collagen products, such as collagen powder, gel, and matrix; and calci… Read more

Procyon Corporation - Asset Resilience Ratio

Latest as of September 2024: 18.18%

Procyon Corporation (PCYN) has an Asset Resilience Ratio of 18.18% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
$582.68K
Cash + Short-term Investments
Total Assets
$3.20 Million
All company assets
Resilience Assessment
Good
Financial Resilience Level

Asset Resilience Ratio Trend (2008–2025)

This chart shows how Procyon Corporation's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Procyon Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $582.68K 18.18%
Total Liquid Assets $582.68K 18.18%

Asset Resilience Insights

  • Good Liquidity Position: Procyon Corporation maintains a healthy 18.18% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Procyon Corporation Industry Peers by Asset Resilience Ratio

Compare Procyon Corporation's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA
Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227
Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for Procyon Corporation (2008–2025)

The table below shows the annual Asset Resilience Ratio data for Procyon Corporation.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-06-30 9.65% $332.77K $3.45 Million -8.54pp
2024-06-30 18.18% $582.68K $3.20 Million +2.40pp
2023-06-30 15.78% $562.47K $3.56 Million +8.39pp
2022-06-30 7.39% $281.11K $3.80 Million +0.78pp
2021-06-30 6.61% $280.44K $4.24 Million +1.11pp
2020-06-30 5.50% $155.13K $2.82 Million -0.82pp
2019-06-30 6.32% $153.95K $2.43 Million -0.18pp
2018-06-30 6.51% $153.46K $2.36 Million +2.77pp
2017-06-30 3.74% $102.14K $2.73 Million -1.13pp
2016-06-30 4.87% $152.00K $3.12 Million -1.39pp
2015-06-30 6.27% $157.67K $2.52 Million +0.29pp
2014-06-30 5.98% $157.15K $2.63 Million +0.09pp
2013-06-30 5.89% $156.42K $2.66 Million -3.06pp
2008-06-30 8.95% $239.70K $2.68 Million --
pp = percentage points